Does the media prefer CLPT or SKIN?

In the previous week, Beauty Health had 10 more articles in the media than ClearPoint Neuro. MarketBeat recorded 12 mentions for Beauty Health and 2 mentions for ClearPoint Neuro. Beauty Health's average media sentiment score of 0.99 beat ClearPoint Neuro's score of -0.07 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beauty Health 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CNXU or SKIN?

Beauty Health has a consensus price target of $2.02, indicating a potential upside of 232.46%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts plainly believe Beauty Health is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Beauty Health 1 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, CNXU or SKIN?

Conexeu Sciences has higher earnings, but lower revenue than Beauty Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Beauty Health $300.80M 0.26 -$9.52M -$0.17 N/A

Does the media prefer CNXU or SKIN?

In the previous week, Beauty Health had 8 more articles in the media than Conexeu Sciences. MarketBeat recorded 12 mentions for Beauty Health and 4 mentions for Conexeu Sciences. Beauty Health's average media sentiment score of 0.99 beat Conexeu Sciences' score of 0.55 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beauty Health 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, CARL or SKIN?

Beauty Health has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Carlsmed $50.51M 5.96 -$29.63M -$2.51 N/A Beauty Health $300.80M 0.26 -$9.52M -$0.17 N/A

Is CARL or SKIN more profitable?

Beauty Health has a net margin of -2.03% compared to Carlsmed's net margin of -57.76%. Beauty Health's return on equity of -9.38% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Beauty Health -2.03% -9.38% -1.21%

Does the media refer more to CARL or SKIN?

In the previous week, Beauty Health had 11 more articles in the media than Carlsmed. MarketBeat recorded 12 mentions for Beauty Health and 1 mentions for Carlsmed. Beauty Health's average media sentiment score of 0.99 beat Carlsmed's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beauty Health 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Beauty Health (SKIN) Competitors

$0.61 0.00 (-0.44%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$0.61 0.00 (-0.10%)

As of 06/5/2026 07:35 PM Eastern

Compare

SKIN vs. CLPT, DCTH, CNXU, CV, and CARL

Should you buy Beauty Health stock or one of its competitors? MarketBeat compares Beauty Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beauty Health include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Conexeu Sciences (CNXU), CapsoVision (CV), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does Beauty Health compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

Beauty Health has a net margin of -2.03% compared to ClearPoint Neuro's net margin of -71.57%. Beauty Health's return on equity of -9.38% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Beauty Health	-2.03%	-9.38%	-1.21%

ClearPoint Neuro has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market.

ClearPoint Neuro currently has a consensus price target of $18.00, indicating a potential upside of 39.64%. Beauty Health has a consensus price target of $2.02, indicating a potential upside of 232.46%. Given Beauty Health's higher possible upside, analysts plainly believe Beauty Health is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Beauty Health had 10 more articles in the media than ClearPoint Neuro. MarketBeat recorded 12 mentions for Beauty Health and 2 mentions for ClearPoint Neuro. Beauty Health's average media sentiment score of 0.99 beat ClearPoint Neuro's score of -0.07 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beauty Health	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 40.3% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Beauty Health has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	10.46	-$25.54M	-$1.01	N/A
Beauty Health	$300.80M	0.26	-$9.52M	-$0.17	N/A

Summary

Beauty Health beats ClearPoint Neuro on 12 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Beauty Health has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

Delcath Systems has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.32	$2.70M	$0.01	1,067.00
Beauty Health	$300.80M	0.26	-$9.52M	-$0.17	N/A

Delcath Systems has a net margin of 0.62% compared to Beauty Health's net margin of -2.03%. Delcath Systems' return on equity of 0.51% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Beauty Health	-2.03%	-9.38%	-1.21%

Delcath Systems currently has a consensus price target of $22.50, suggesting a potential upside of 110.87%. Beauty Health has a consensus price target of $2.02, suggesting a potential upside of 232.46%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Beauty Health had 12 more articles in the media than Delcath Systems. MarketBeat recorded 12 mentions for Beauty Health and 0 mentions for Delcath Systems. Beauty Health's average media sentiment score of 0.99 beat Delcath Systems' score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Delcath Systems	Neutral
Beauty Health	Positive

Summary

Delcath Systems beats Beauty Health on 9 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Beauty Health (NASDAQ:SKIN) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Conexeu Sciences has a net margin of 0.00% compared to Beauty Health's net margin of -2.03%. Conexeu Sciences' return on equity of 0.00% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Beauty Health	-2.03%	-9.38%	-1.21%

In the previous week, Beauty Health had 8 more articles in the media than Conexeu Sciences. MarketBeat recorded 12 mentions for Beauty Health and 4 mentions for Conexeu Sciences. Beauty Health's average media sentiment score of 0.99 beat Conexeu Sciences' score of 0.55 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beauty Health	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health has a consensus price target of $2.02, indicating a potential upside of 232.46%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts plainly believe Beauty Health is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Conexeu Sciences has higher earnings, but lower revenue than Beauty Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Beauty Health	$300.80M	0.26	-$9.52M	-$0.17	N/A

Summary

Beauty Health beats Conexeu Sciences on 8 of the 11 factors compared between the two stocks.

How does Beauty Health compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Beauty Health (NASDAQ:SKIN) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

Beauty Health has a net margin of -2.03% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Beauty Health	-2.03%	-9.38%	-1.21%

CapsoVision presently has a consensus price target of $8.50, suggesting a potential upside of 18.22%. Beauty Health has a consensus price target of $2.02, suggesting a potential upside of 232.46%. Given Beauty Health's higher possible upside, analysts plainly believe Beauty Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Beauty Health has higher revenue and earnings than CapsoVision. Beauty Health is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	26.51	-$25.32M	-$2.34	N/A
Beauty Health	$300.80M	0.26	-$9.52M	-$0.17	N/A

93.3% of Beauty Health shares are owned by institutional investors. 2.3% of CapsoVision shares are owned by insiders. Comparatively, 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Beauty Health had 12 more articles in the media than CapsoVision. MarketBeat recorded 12 mentions for Beauty Health and 0 mentions for CapsoVision. Beauty Health's average media sentiment score of 0.99 beat CapsoVision's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Overall Sentiment
CapsoVision	Neutral
Beauty Health	Positive

Summary

Beauty Health beats CapsoVision on 10 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Beauty Health (NASDAQ:SKIN) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Beauty Health has a net margin of -2.03% compared to Carlsmed's net margin of -57.76%. Beauty Health's return on equity of -9.38% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Beauty Health	-2.03%	-9.38%	-1.21%

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Beauty Health has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	5.96	-$29.63M	-$2.51	N/A
Beauty Health	$300.80M	0.26	-$9.52M	-$0.17	N/A

In the previous week, Beauty Health had 11 more articles in the media than Carlsmed. MarketBeat recorded 12 mentions for Beauty Health and 1 mentions for Carlsmed. Beauty Health's average media sentiment score of 0.99 beat Carlsmed's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beauty Health	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Carlsmed currently has a consensus target price of $19.33, indicating a potential upside of 74.65%. Beauty Health has a consensus target price of $2.02, indicating a potential upside of 232.46%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Beauty Health beats Carlsmed on 12 of the 15 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKIN vs. The Competition

Export

Metric	Beauty Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$78.74M	$8.70B	$6.68B	$11.99B
Dividend Yield	N/A	1.76%	2.67%	5.55%
P/E Ratio	-3.57	22.29	24.06	23.63
Price / Sales	0.26	20.38	516.17	112.20
Price / Cash	3.98	88.45	42.23	54.60
Price / Book	1.27	5.20	9.73	6.35
Net Income	-$9.52M	$175.77M	$3.57B	$337.59M
7 Day Performance	-21.48%	-2.20%	-1.28%	-2.52%
1 Month Performance	-33.23%	7.06%	1.38%	-0.03%
1 Year Performance	-62.03%	3.44%	23.93%	25.34%

Beauty Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKIN Beauty Health	3.1942 of 5 stars	$0.61 -0.4%	$2.02 +232.5%	-62.0%	$78.74M	$300.80M	N/A	1,030
CLPT ClearPoint Neuro	2.8624 of 5 stars	$12.09 -4.4%	$18.00 +48.9%	-7.5%	$379.07M	$40.61M	N/A	110
DCTH Delcath Systems	1.9275 of 5 stars	$10.49 -1.1%	$22.50 +114.6%	-34.9%	$365.93M	$90.44M	1,049.90	60	Gap Up
CNXU Conexeu Sciences	N/A	$15.65 +10.8%	N/A	N/A	$356.81M	N/A	N/A	4	News Coverage High Trading Volume
CV CapsoVision	1.0254 of 5 stars	$6.90 +0.0%	$8.50 +23.2%	N/A	$338.76M	$13.56M	N/A	90	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKIN) was last updated on 6/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beauty Health (SKIN) Competitors

SKIN vs. CLPT, DCTH, CNXU, CV, and CARL

How does Beauty Health compare to ClearPoint Neuro?

Summary

How does Beauty Health compare to Delcath Systems?

Summary

How does Beauty Health compare to Conexeu Sciences?

Summary

How does Beauty Health compare to CapsoVision?

Summary

How does Beauty Health compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beauty Health (SKIN) Competitors

SKIN vs. CLPT, DCTH, CNXU, CV, and CARL

How does Beauty Health compare to ClearPoint Neuro?

Is CLPT or SKIN more profitable?

Which has more volatility & risk, CLPT or SKIN?

Do analysts recommend CLPT or SKIN?

Does the media prefer CLPT or SKIN?

Do institutionals & insiders have more ownership in CLPT or SKIN?

Which has higher earnings & valuation, CLPT or SKIN?

Summary

How does Beauty Health compare to Delcath Systems?

Which has more risk & volatility, DCTH or SKIN?

Which has higher earnings & valuation, DCTH or SKIN?

Is DCTH or SKIN more profitable?

Do analysts rate DCTH or SKIN?

Do insiders & institutionals hold more shares of DCTH or SKIN?

Does the media refer more to DCTH or SKIN?

Summary

How does Beauty Health compare to Conexeu Sciences?

Do insiders and institutionals have more ownership in CNXU or SKIN?

Is CNXU or SKIN more profitable?

Does the media prefer CNXU or SKIN?

Do analysts recommend CNXU or SKIN?

Which has better earnings and valuation, CNXU or SKIN?

Summary

How does Beauty Health compare to CapsoVision?

Is CV or SKIN more profitable?

Do analysts rate CV or SKIN?

Which has stronger earnings and valuation, CV or SKIN?

Do institutionals & insiders hold more shares of CV or SKIN?

Does the media favor CV or SKIN?

Summary

How does Beauty Health compare to Carlsmed?

Is CARL or SKIN more profitable?

Do insiders & institutionals believe in CARL or SKIN?

Which has stronger valuation and earnings, CARL or SKIN?

Does the media refer more to CARL or SKIN?

Do analysts prefer CARL or SKIN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools